ReviewInternational journal of hematology2023
Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS.
Yuho NajimaPubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it